Wound Contact Layer Containing Treatment Material Patents (Class 602/48)
  • Patent number: 10390997
    Abstract: A medicinal product (10) is for the care of an individual having at least one injury such as a burn wound or a skin abrasion, in particular with a large surface area. The product includes at least one functional surface (12, 12?, 14) to at least partially cover the injury and/or to fix the medicinal product (10) to the individual. At least one functional surface (12, 12?) includes stem parts (18) protruding from the surface. The free end-faces of the stem parts form an adhesion section able to adhere at least partially to the individual and/or to a further functional surface (12?), predominantly by Van der Waals forces.
    Type: Grant
    Filed: May 28, 2013
    Date of Patent: August 27, 2019
    Assignee: GOTTLIEB BINDER GMBH & CO. KG
    Inventor: Jan Tuma
  • Patent number: 10293075
    Abstract: The invention relates to porous absorbent Composite Material, which may be used e.g. in the form of a plug or tampon, for instance for controlling bleeding, wound closure, prevent tissue adhesion and/or support tissue regeneration. The invention provides a hydrophilic Self-Dispersive, fragmentable and Bio-Absorbable Porous Composite foams, suitable for packing antrum or other cavities of the body, comprising of composite of polymers, which polymer preferably comprises —C(O)—O—; NH2/3+; —OH; —CH2OCH2C(O)O— groups as functional or —CH—O— (e.g. C2H4O; C6H10O5; C6H8O6); —CH—N—O— (e.g. C8H13NO5); O—C—C— (e.g. O—CH2-CH2); —C(O)N— groups in the backbone of the polymers e.g. gelatin, chitosan, collagen, alginate, polyvinyl alcohol, polyethylene glycol, keratin, cellulose.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: May 21, 2019
    Assignee: DATT LIFE SCIENCES PRIVATE LIMITED
    Inventors: Rajan Datt, Ramadhar Kumar, Siddharth Pandey, Pallavi Shrivastava
  • Patent number: 10213225
    Abstract: Robotic debridement apparatuses, related systems, and methods of using the same are disclosed herein. The robotic debridement apparatuses are configured to facilitate debridement of tissue from a body region. For example, the robotic debridement apparatuses can include one or more of at least one debriding tool configured to debride tissue, at least one debris disposal device configured to capture substances in the body region. The systems disclosed herein can include a plurality of robotic debridement apparatuses. The systems disclosed herein can include a dressing associated with the plurality of robotic debridement apparatuses. The dressing can be associated with the robotic debridement apparatuses in a manner that facilitates operations of the robotic debridement apparatuses.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: February 26, 2019
    Assignee: ELWHA LLC
    Inventors: Michael H. Baym, Mahalaxmi Gita Bangera, Hon Wah Chin, Roderick A. Hyde, Jordin T. Kare, Nathan P. Myhrvold, Elizabeth A. Sweeney
  • Patent number: 10166260
    Abstract: A wound care product in the form of a gel is provided, and contains protein from egg shell membrane. The gel is made by first hydrating the egg shell membrane powder and then adding carbomer to partially neutralize the egg shell membrane. The neutralization is completed with the addition of triethanolamine, so as to form a homogeneous gel with a smooth consistency. An antimicrobial compound and a tissue growth accelerator are added to the gel. The gel, infused with egg shell membrane, is applied directly to the wound tissue to form a barrier trapping the active ingredients adjacent the wound site and inhibiting penetration of outside bacteria into the wound site.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: January 1, 2019
    Assignee: Blaine Laboratories, Inc.
    Inventors: Robert C. Blaine, Thang D. Ngo
  • Patent number: 9867692
    Abstract: The present invention provides for methods and devices suitable for producing a transplantable cellular suspension of living tissue suitable for grafting to a patient. In applying the method and/or in using the device, donor tissue is harvested, subjected to a cell dissociation treatment, cells suitable for grafting back to a patient are collected and dispersed in a solution that is suitable for immediate dispersion over the recipient graft site.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: January 16, 2018
    Assignee: Avita Medical Ltd.
    Inventors: Fiona M. Wood, Marie L. Stoner
  • Patent number: 9827060
    Abstract: An interface component is provided for use with a first glove and a medical equipment component. The interface component comprises at least one switch located on the first glove, where each of the at least one switch provides a control signal to the medical equipment component. The interface component may further comprise a controller coupled to the plurality of switches, a power supply module coupled to the controller, and a wireless communications interface coupled to the controller in communication with a wireless interface of the medical equipment component.
    Type: Grant
    Filed: July 15, 2014
    Date of Patent: November 28, 2017
    Assignee: Synaptive Medical (Barbados) Inc.
    Inventor: Victor Jagga
  • Patent number: 9801750
    Abstract: A limb protective covering (10) includes an elongated sleeve (11) and an adjustable, elastic retaining strap (12). The sleeve has a closed end (15) and an open end (16) opposite the closed end. The sleeve is made of a high performance elastomeric polymer blend, such as a styrene-butadiene-styrene (SBS) based monolayer elastomeric antistatic film having a coefficient of friction of at least 0.6.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: October 31, 2017
    Assignee: ALBAHEALTH, LLC
    Inventor: Ronnie Thompson
  • Patent number: 9789303
    Abstract: A pad for electrically stimulated wound healing, including a pad configured to be placed on a wound, at least one anode disposed on the pad to contact the wound, and at least one cathode disposed on the pad to contact the wound, the at least one cathode being disposed separately from the at least on anode. The pad wherein the at least one anode and the at least one cathode in contact with the wound provide a flow of electrical current in an intended direction through the wound based on the separate locations of the at least one anode and the at least one cathode.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: October 17, 2017
    Inventor: Morton M. Mower
  • Patent number: 9737631
    Abstract: Disclosed herein is a method of attaching a medical device to a surface, the medical device having at least one adhesive area, wherein the method comprises the steps of: contacting the surface with a composition comprising a T silicone resin and/or a DT silicone resin and/or an MQ silicone resin and/or an MT silicone resin, thereby providing non-tacky coating on the surface; and attaching the adhesive area to the surface such that the composition is located between, and in contact with, the surface and the adhesive area, thereby attaching medical device to the surface; thereby achieving an improve adherence between the medical device and the surface.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: August 22, 2017
    Assignee: MÖLNLYCKE HEALTH CARE AB
    Inventor: Dennis Hansson
  • Patent number: 9687584
    Abstract: A biocompatible polymeric composition for cross-linking in-situ in a wound is disclosed comprising 1) one or more polyanionic polymers such as alginates or hyaluronates, able to be cross-linked the surface of the wound and 2) one or more polycationic polymers such as chitosan or DEAE-Dextran, that assists in the solidification process as well as speeds up hemostasis without the need for applying pressure. The biocompatible polymeric composition may further comprise a cross-linking agent such as aqueous calcium chloride. The invention encompasses an initial polymeric composition, the solidified matrix cross-linked and integrated at the wound site, including the methods of using, applying, and cross-linking the composition.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: June 27, 2017
    Assignee: Cresilon, Inc.
    Inventor: Joseph A. Landolina
  • Patent number: 9408827
    Abstract: Sheet for cutaneous application comprising a support layer made of loosely woven fabric embedded in a layer of silicone elastomer incorporating vitamin E or an ester thereof, wherein the layer of silicone elastomer has a thickness less than or equal to 2.0 mm and the silicone elastomer contains an elasticity modifier consisting of a triglyceride of saturated C8-C18 fatty acids.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: August 9, 2016
    Assignee: BIO.LO.GA S.R.L.
    Inventor: Giorgio Panin
  • Patent number: 9259357
    Abstract: A thin chitosan-based material can be used for biomedical applications. The chitosan has been treated in a nitrogen field by applying energy to ionize nitrogen in and around the chitosan material. A single or multiple such treatments may be employed. For example, the chitosan material may be irradiated under nitrogen using ?-irradiation, treated under a nitrogen plasma, or both. A thin chitosan material can be readily treated by surface modifying treatments such as irradiating under nitrogen using ?-irradiation, treating under a nitrogen plasma, or both.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: February 16, 2016
    Assignees: Loma Linda University, Loma Linda University Medical Center, North Carolina State University
    Inventors: Wolff M. Kirsch, Samuel M. Hudson, Andrew Crofton
  • Patent number: 9237945
    Abstract: A tubular tissue graft device is provided comprising a tubular tissue and a restrictive fiber matrix of a bioerodible polymer about a circumference of the tubular tissue. The matrix may be electrospun onto the tubular tissue. In one embodiment, the tubular tissue is from a vein, such as a saphenous vein, useful as an arterial graft, for example and without limitation, in a coronary artery bypass procedure. Also provided is method of preparing a tubular graft comprising depositing a fiber matrix of a bioerodible polymer about a perimeter of a tubular tissue to produce a tubular tissue graft device. A cardiac bypass method comprising bypassing a coronary artery with a tubular tissue graft device comprising a vein and a restrictive fiber matrix of a bioerodible polymer about a circumference of the vein also is provided.
    Type: Grant
    Filed: January 30, 2008
    Date of Patent: January 19, 2016
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Mohammed S. El-Kurdl, Yi Hong, Lorenzo Soletti, John J. Stankus, David A. Vorp, William R. Wagner
  • Patent number: 9186273
    Abstract: The present disclosure is drawn to methods for treating various types of pain. Specifically, a method for treating various types of pain includes the application of an analgesic system to a skin surface of a subject experiencing the pain and maintaining the analgesic system on the skin surface for a period of time of at least 30 minutes. The analgesic system applied to the skin surface can include a heating component and a local anesthetic formulation which includes at least one local anesthetic. The heating component can be capable of heating the skin surface to a temperature of 36° C. to 42° C.
    Type: Grant
    Filed: May 4, 2010
    Date of Patent: November 17, 2015
    Assignee: Nuvo Research Inc.
    Inventors: Jie Zhang, Robert Lippert
  • Patent number: 9186334
    Abstract: The present disclosure is drawn to methods for treating various types of pain, including pain associated nerve entrapment, neuroma, headaches, connective tissue, arthritis, injury, and/or overuse. Specifically, the method includes the application of an analgesic system to a skin surface of a subject experiencing the pain and maintaining the analgesic system on the skin surface for an application period of at least 30 minutes. Following the application period the analgesic system can be removed and the subject being treated continues to experience reduction of pain for a period of 2 to 10, or even 4 to 12 hours after removal of the analgesic system. The analgesic system applied to the skin surface can include a heating component and a local anesthetic formulation.
    Type: Grant
    Filed: March 16, 2011
    Date of Patent: November 17, 2015
    Assignee: Nuvo Research Inc.
    Inventors: Jie Zhang, Robert Lippert
  • Patent number: 9101508
    Abstract: The various embodiments herein provide an electro spun wound dressing comprising three nano fibrous layers and a method of synthesizing the same. The outer polymeric layer acts as a support layer for the other two layers and is hydrophilic in nature. The middle layer comprises a genipin cross linked reservoir layer loaded with a herbal extract of Melilotus officinalis and is hydrophobic or hydrophilic in nature. The second layer is cross-linked to control a release of the Melilotus officinalis extract in an aqueous environment. The third layer is a wound contacting inner layer comprising a non-cross-linked chitosan based nanofibrous layer that is hydrophilic in nature. Various additives are provided to enhance the mechanical or the chemical properties of the wound dressing and to control a release profile of the herbal extract.
    Type: Grant
    Filed: December 7, 2011
    Date of Patent: August 11, 2015
    Inventors: Esmaeil Mirzaei, Reza Faridi Majidi, Saeed Sarkar, Seyed Mehdi Rezayat
  • Patent number: 9050210
    Abstract: A system for applying a reduced pressure at a tissue site includes a reduced pressure source, a porous pad in fluid communication with the reduced pressure source, and a drape positionable over the porous pad to seal the porous pad at the tissue site. The porous pad includes a plurality of channel walls to form a plurality of channels between the channel walls. The channel walls are substantially liquid impermeable to prevent movement of a liquid through the channel walls but are gas permeable to allow movement of a gas through the channel walls as reduced pressure is applied at the tissue site. The liquid impermeability of the channel walls and the application of reduced pressure causes flow of the liquid to occur through the plurality of channels.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: June 9, 2015
    Assignee: KCI Licensing, Inc.
    Inventor: Jonathan Scott Olson
  • Publication number: 20150133844
    Abstract: An elongate adhesive article having a length substantially greater than a width includes a backing layer having an adhesive layer and a single weakened region formed of a removable strip of backing layer that is oriented substantially perpendicular to the article length. The removable strip of backing layer is at least partially defined by a pair of lines of weakness separated by a gap of between about 2 and about 15 mm. The elongate article may include an absorbent pad in the form of an adhesive bandage or sticking plaster. A method of using such an elongate article includes the steps of applying the article to the skin of a mammal, removing a predefined strip from the article; and removing the remainder of the article from the skin.
    Type: Application
    Filed: November 8, 2013
    Publication date: May 14, 2015
    Applicant: Johnson & Johnson Consumer Companies, Inc.
    Inventor: Shannon Montulet
  • Publication number: 20150118284
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and thrombin, wherein the thrombin is present in an amount between 0.250 Units/mg of fibrinogen component and 0.062 Units/mg of fibrinogen component. Also disclosed are methods for treating wounded tissue.
    Type: Application
    Filed: December 24, 2014
    Publication date: April 30, 2015
    Inventors: Martin MacPhee, Dawson Beall
  • Patent number: 9017717
    Abstract: A bandage includes a reservoir filled with a perfluorochemical fluid, saturated with oxygen. Oxygen passes through a permeable membrane to the skin or wound to promote healing, and carbon dioxide travels from the skin or wound to the reservoir.
    Type: Grant
    Filed: April 6, 2006
    Date of Patent: April 28, 2015
    Assignee: Peach Technologies LLC
    Inventors: Thomas H. Shaffer, Robert G. Stern, Marla R. Wolfson
  • Publication number: 20150110843
    Abstract: Fibrous antimicrobial materials for use in structures and barrier applications, such as face masks and wound dressings, have been developed from antimicrobial polymeric materials. The fibrous antimicrobial materials also are particularly suitable for use in air and water filtration. The antimicrobial polymeric materials are prepared from solid solutions of antimicrobial bisguanide compounds blended with certain thermoplastic polymers. The antimicrobial polymeric materials may be extruded into fibers or used in the particulate form for preparation of the nonwoven antimicrobial materials. The antimicrobial bisguanide compound, such as chlorhexidine, are distributed at the molecular level within at least one thermoplastic polymer, such as a polyolefin in which the antimicrobial bisguanide compound is soluble, to form a miscible blend. Methods for their formation and use also are provided.
    Type: Application
    Filed: December 23, 2014
    Publication date: April 23, 2015
    Inventors: Jan W. Gooch, Thomas J. Steimer, SR.
  • Publication number: 20150065936
    Abstract: A wound dressing for covering a wound is formed of at least one absorbing member and a plurality of elongated activated carbon fibers. The at least one absorbing member is made of a foamed polymeric material and includes a plurality of pores. The activated carbon fibers are distributed in the at least one absorbing member and partially protrude into the pores. Each of the activated carbon fibers has a diameter of 2-15 ?m and a length of 40-1500 ?m. In light of the above, the tissue fluid leaking from the wound can be absorbed by the absorbing member to prevent the wound from soakage and the activated carbon fibers inside the absorbing member can emit far-infrared rays to promote the blood circulation around the wound for quickening healing of the wound.
    Type: Application
    Filed: September 4, 2013
    Publication date: March 5, 2015
    Applicant: BIO-MEDICAL CARBON TECHNOLOGY CO., LTD.
    Inventors: Tse-Hao KO, Jui-Hsiang LIN, Pei-Hsun CHOU, Yen-Ju SU
  • Patent number: 8969649
    Abstract: A device for the dressing of wounds and insertion sites of percutaneous and drug delivery devices provides 360 degree or complete circumferential protection of a wound or insertion site of a percutaneous or drug delivery device. In particular, the device is an integrated dressing for catheters comprising a pad and an adhesive dressing.
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: March 3, 2015
    Assignee: Ethicon, Inc.
    Inventors: Rebecca Leibowitz, Sandra Gensini, Joseph Zavatsky
  • Patent number: 8962908
    Abstract: A wound dressing material comprising a polymeric substrate, a silver salt, and a dyestuff to photostabilize the silver salt. The substrate may comprise collagen and/or oxidized regenerated cellulose complexed to Ag+, and the dyestuff may for example be an aniline or acridine dye.
    Type: Grant
    Filed: February 27, 2012
    Date of Patent: February 24, 2015
    Assignee: Systagenix Wound Management (US), Inc.
    Inventors: Deborah Addison, David Greenhalgh, Breda Mary Cullen
  • Patent number: 8951599
    Abstract: A wound dressing and a method of making the wound dressing is described herein. The wound dressing is formed of an absorbent substrate formed of one or more layers and a low-adherence layer disposed on the substrate. The low-adherence layer can be disposed within at least a portion of the substrate. The low-adherence layer is formed of a mixture of at least one highly fluorinated polymer and at least one acidic polymer. The at least one highly fluorinated polymer has a fluorine content greater than the fluorine content of the at least one acidic polymer.
    Type: Grant
    Filed: November 15, 2012
    Date of Patent: February 10, 2015
    Assignee: International Business Machines Corporation
    Inventors: Robert D. Allen, Christopher E. Bannister, Jere J. Brophy, Richard A. DiPietro
  • Patent number: 8938898
    Abstract: Devices in which components of medical kits are carried are identifiable by means other than by the naked eye. The means for identification is attached to or integral with the device and may comprise raised and lowered surfaces that can be read by touch; serrations disposed on an edge or surface; a fluorescent coating viewable under infrared or ultraviolet light; or a pattern that is viewable using a thermal imaging device such as night vision goggles. A package for retaining a medical item includes an identifying element of a material that is selectively viewable in response to light attributes of the material. A device for the visual identification of a package containing a medical item includes an identifying element comprising a material that is visually discernible in reduced-light environments via the use of night vision devices.
    Type: Grant
    Filed: December 6, 2006
    Date of Patent: January 27, 2015
    Assignee: Z-Medica, LLC
    Inventors: Denny Lo, Robert Huebner, Jessica Perkins, Thomas Signore
  • Publication number: 20150024029
    Abstract: A dressing composition for use as a skin dressing comprises an elastomeric-adhesive composition, and a zeolite comprising releasably adsorbed nitric oxide. The zeolite may comprise a transition metal cation such as Co, Fe, Mn, Ni, Cu, Zn, Ag or a mixture thereof as an extra-framework metal cation, preferably Zn. The elastomeric adhesive composition may be a hydrocolloid-adhesive composition comprising, hydrocolloid and elastomer. The dressing composition releases nitric oxide, which may have beneficial effects, when used on wounds or moist skin, with a substantially constant release rate over a long period of time. A dressing including a layer of the dressing composition has a backing layer and may have a release liner removably attached to the skin-contacting surface of the dressing layer.
    Type: Application
    Filed: August 13, 2014
    Publication date: January 22, 2015
    Inventors: Abraham Araya, Alan Reginald Minihan, Paul Matthew Robbins, Sonya Theresa Broderick, Michael J. Waring
  • Publication number: 20150018742
    Abstract: In one embodiment, a medical device for containing or applying a pressure or a combination thereof to an area of skin or wound of a user is provided. The medical device includes a bandage body, a pad component disposed thereon, body, an adhesive component, and an opening adjacent to the first end of the bandage body, wherein the opening is configured to receive at least a portion of the bandage body such that when the second end of the bandage body is received within the opening, the adhesive portion of bandage body can be attached to a portion of the bandage body such that the adhesive does not contact the user.
    Type: Application
    Filed: July 10, 2013
    Publication date: January 15, 2015
    Inventor: John Adam Baumgartner
  • Patent number: 8916741
    Abstract: A wound closure system having first, second and third adhesive pads with a pair of strap members fixedly secured to the first and third adhesive pads. The pair of strap members are slidably received within the second adhesive pad. When the third adhesive pad is displaced, the first and second adhesive pads are displaced toward each other to close the wound.
    Type: Grant
    Filed: December 17, 2012
    Date of Patent: December 23, 2014
    Inventors: Robert E. Fischell, Leigh Vinocur
  • Publication number: 20140371650
    Abstract: A unique multi-functional emergency bandage is introduced, wherein bleeding is stopped by: (1) optimizing mechanical properties and preventing ischemia and/or necrosis while applying enough pressure to help stop bleeding, and (2) incorporating inorganic anti-bleeding nano-structures (embedded within a gauze and/or microbial cellulose) with almost infinite life-time. Additionally, pathogen passage through the bandage is prohibited (via an intermediate filter layer). Together with the overall anti-microbial character of the bandage, the unique multi-functional bandage offers all these vital features within a single design. The unique bandage can be applied by using a single hand and bandaging direction can be changed using a unique binding apparatus.
    Type: Application
    Filed: June 18, 2013
    Publication date: December 18, 2014
    Inventors: Ozgur Cobanoglu, Jitka Eryilmaz, Deniz Sener, Mehmet Eryilmaz
  • Publication number: 20140364712
    Abstract: Devices and methods relate to inducing or promoting hemostasis. The hemostasis device may include a support layer having a first surface and an opposing second surface. The device may include a layer, the layer disposed on the first surface. The layer may include a target surface configured to contact a target site. The layer may include a monolayer of about 100% graphene or may include laser-reduced graphene oxide. The device may include a sensor configured to measure a level of hemostasis of the target site. The methods relate to a method of manufacturing a hemostatic device including a monolayer of graphene or a layer of laser-reduced graphene oxide.
    Type: Application
    Filed: March 4, 2013
    Publication date: December 11, 2014
    Applicant: EMORY UNIVERSITY
    Inventors: Wilbur A. Lam, Anton Sidorov, Zhigang JIang
  • Publication number: 20140364788
    Abstract: The present invention relates to an adherent interface dressing intended for application directly to a wound.
    Type: Application
    Filed: December 12, 2012
    Publication date: December 11, 2014
    Inventors: Serge Lecomte, Jean-Marc Pernot
  • Patent number: 8907153
    Abstract: The present invention is drawn to adhesive peel-forming formulations for dermal delivery of a drug. The formulation can include a drug, a solvent vehicle, and a peel-forming agent. The solvent vehicle can include a volatile solvent system having one or more volatile solvent, and a non-volatile solvent system having one or more non-volatile solvent, wherein the non-volatile solvent system has a solubility for the drug that is within a window of operable solubility for the drug such that the drug can be delivered at therapeutically effective rates over a sustained period of time. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified peelable layer after at least a portion of the volatile solvent system is evaporated.
    Type: Grant
    Filed: June 6, 2005
    Date of Patent: December 9, 2014
    Assignee: Nuvo Research Inc.
    Inventors: Jie Zhang, Kevin S. Warner, Michael A. Ashburn, Larry D. Rigby, Suyi Niu
  • Publication number: 20140358058
    Abstract: A wound dressing and method of forming the same. In one embodiment, the wound dressing includes a two-sided adhesive band conformable to a surface of a person. The wound dressing also includes a removable bandage configured to attach to an upper surface of and seat over the two-sided adhesive band, thereby forming a substantially closed structure for application over a wound on the surface of the person.
    Type: Application
    Filed: May 30, 2013
    Publication date: December 4, 2014
    Inventor: Andrew Nelson
  • Publication number: 20140341865
    Abstract: There is provided a dressing for treating a wound. The dressing for healing a wound can be useful in maintaining a moisture environment at a wound site using a biocompatible polymer scaffold, and effectively promoting healing of a wound by various growth factors secreted by skin cells or stem cells attached to the biocompatible polymer scaffold as well.
    Type: Application
    Filed: December 12, 2012
    Publication date: November 20, 2014
    Applicant: TEGO SCIENCE INC.
    Inventors: Saewha Jeon, Yun Hee Kim, Ho Yun Chung, Jin Hyun Choi, Hankyu Jang
  • Publication number: 20140336557
    Abstract: The Technology described herein applies to medical dressings designed to heal wounds in the area of advanced wound care, inclusive of Negative Pressure Wound Therapy (NPWT), and describes novel wound healing absorbent scaffolds and dressing based on natural and naturally-derived material and fibers, preferentially poly (lactic) acid fibers and alginate materials.
    Type: Application
    Filed: May 1, 2014
    Publication date: November 13, 2014
    Inventors: Kerem Durdag, Valerie Gunn, Brittany Paul, Robert Hamlyn, Brian Pendleton, Marc Etchells
  • Patent number: 8884094
    Abstract: A vacuum bandage is provided for use with a wound having a wound surface. The bandage is connectable to a vacuum source and includes a wound dressing member having a wound contacting surface, a top surface, and a port configured for communication with the vacuum source. The wound dressing member further includes holes in the wound contacting surface configured for communication with the wound surface of the wound and a passageway between the port and each hole. The vacuum bandage further includes a pack adjacent to the top surface of the member. The pack may include an aperture positioned about the port.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: November 11, 2014
    Assignee: KCI Licensing, Inc.
    Inventors: Jeffrey S. Lockwood, Robert Petrosenko
  • Patent number: 8882729
    Abstract: The invention relates to a transdermal therapeutic system made of the following layers: a carrier layer (T), an active ingredient layer (R), a membrane layer (M) and optionally an adhesive layer (K), wherein the carrier layer (T) is impenetrable to the active substance and to water, the active substance layer (R) comprises as an active substance component the salt of an alkali reactive active substance, such as a CNS-active amine in combination with at least one alkali reactive further component, and a polymer component (P1), wherein the active substance is released from the active substance layer (R) only by the moisture entering from the exterior through the membrane layer (M), and the membrane layer (M) is made of a polymer component (P2), allowing a uniform delivery of basic active substances to the skin.
    Type: Grant
    Filed: February 28, 2009
    Date of Patent: November 11, 2014
    Assignee: LTS Lohmann Therapie Systeme AG
    Inventors: Michael Horstmann, Patrick Mohr, Mohammad Sameti
  • Publication number: 20140330192
    Abstract: A dressing for application to a wound or burn is provided. The dressing includes a substrate and an amount of therapeutic healing compound applied to the substrate. The therapeutic healing compound includes a sugarcane plant extract, a gelling agent including at least one of xanthan gum and hydroxyethyl cellulose, and collagen.
    Type: Application
    Filed: July 17, 2014
    Publication date: November 6, 2014
    Inventor: Steven C. Denstman
  • Publication number: 20140309569
    Abstract: A dressing support system and method of use for bandaging patient wounds in an efficient, cost effective, and repeatable manner by practitioners, non-professionals, and home caregivers according to unique specification dictated by wound care specialist without the need for extensive training or wasted materials of trial and error techniques.
    Type: Application
    Filed: April 12, 2013
    Publication date: October 16, 2014
    Inventor: Diana Lynn Matthews
  • Publication number: 20140309574
    Abstract: Wound dressings, methods for their production and components for use therein. A knitted structure comprising a blend of gelling fibres and non-gelling fibres wherein the yarn comprises at least 50% w/w gelling fibres, a three-dimensional textile material comprising gelling fibres, and a yarn comprising a blend of gelling and non-gelling fibres which may be used in their production, the knitted structure and three-dimensional textile material beings suitable for use as wound dressings or as components of composite wound dressings. The wound dressings may be adapted for use in negative pressure wound therapy (NPWT). It has been found that the incorporation of gel-forming fibres provides a material which has a high absorbency, enabling good transfer of exudates away from a wound, which retains structural integrity, and which is non-adherent and easily removed from the wound.
    Type: Application
    Filed: November 1, 2012
    Publication date: October 16, 2014
    Inventor: Stephen Cotton
  • Publication number: 20140309575
    Abstract: A device for the protection of skin lesions of various kinds, in particular lesions following biopsy interventions, including: a first sheet having a central opening; a spacing element on the first sheet, made of a non-rigid material soaked with substances having bacteriostatic, bactericidal, germicidal or fungicidal activity, and having a central opening of smaller size than the central opening in the first sheet, and the center of which is essentially coincident with the center of the opening in the first sheet, so that part of the spacing element comes into contact with the skin in an area surrounding the lesion; and a second sheet, made with a material having micro-porosity preferably lower than 0.5 m, placed over the spacing element so as to close the top of the central opening in said spacing element and to form, when the device is in contact with the skin, a closed chamber.
    Type: Application
    Filed: October 22, 2012
    Publication date: October 16, 2014
    Inventors: Josek Berek APOLET, Jonathan BYRON, Ofer SPOTTHEIM
  • Publication number: 20140303541
    Abstract: Medical devices, wound dressings, and methods of dressing wounds are described. Devices and methods using silicone and pharmaceutically active agents are described. Devices including covers and bases are described.
    Type: Application
    Filed: November 17, 2011
    Publication date: October 9, 2014
    Inventor: David J. Vachon
  • Publication number: 20140296763
    Abstract: A protective device configured in accordance with a particular embodiment includes a cover including a first region that extends over a vulnerable site on a patient and a second region that extends over an area on the patient peripheral to the vulnerable site. The first region of the cover is at least generally impermeable to liquid water. The device further includes an adhesive film and a liquid-absorbing element. The adhesive film is configured to form an adhesive bond between the second region of the cover and the patient. The bond has an inner edge portion positioned toward the vulnerable site and an outer edge portion positioned away from the vulnerable site. The liquid-absorbing element is configured to absorb liquid contamination at the outer edge portion of the bond and/or liquid contamination approaching the outer edge portion of the bond when the cover is operably positioned on the patient.
    Type: Application
    Filed: March 25, 2014
    Publication date: October 2, 2014
    Applicant: CENORIN, LLC
    Inventors: Art Seguin, Gerry Arambula
  • Publication number: 20140296765
    Abstract: Wound dressing articles comprising a nonwoven web comprising a plurality of fibers having grafted pendant hydrophilic groups, methods that use high energy irradiation for making a plurality of fibers having grafted pendant hydrophilic groups, useful for making wound dressing articles.
    Type: Application
    Filed: August 13, 2012
    Publication date: October 2, 2014
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Cary A. Kipke, John J. Rogers, Michael R. Berrigan, Clinton P. Waller, JR., Douglas E. Weiss
  • Patent number: 8846076
    Abstract: A hemostatic device for promoting the clotting of blood includes a gauze substrate, a clay material disposed on the gauze substrate, and also a polyol such as glycerol or the like disposed on the gauze substrate to bind the clay material. When the device is used to treat a bleeding wound, at least a portion of the clay material comes into contact with blood emanating from the wound to cause the clotting. A bandage that can be applied to a bleeding wound to promote the clotting of blood includes a flexible substrate and a gauze substrate mounted thereon. The gauze substrate includes a clay material and a polyol. A hemostatic sponge also includes a gauze substrate and a dispersion of hemostatic material and a polyol on a first surface of the substrate.
    Type: Grant
    Filed: November 20, 2012
    Date of Patent: September 30, 2014
    Inventors: Raymond J. Huey, Denny Lo, Daniel J. Burns, Giacomo Basadonna, Francis X. Hursey
  • Publication number: 20140288476
    Abstract: Cranial caps designed to serve as an infection barrier and that can easily be placed on and removed from a patient's head are provided herein. Preferred cranial caps include an aperture that can be opened and closed that allows medical personal to easily inspect and/or treat the wound while the patient is wearing the cranial cap.
    Type: Application
    Filed: March 21, 2014
    Publication date: September 25, 2014
    Inventors: Devin Bradford Wright, Frances Patrick Delashaw
  • Publication number: 20140276322
    Abstract: In one aspect, a wound treatment system includes an inner layer comprising a foam material impregnated with a zinc oxide containing composition with or without calamine and/or ichthammol and in the presence or absence of antimicrobial agent (inorganic and/or organic). An optional outer layer comprises a short/long stretch compression bandage. In another aspect, a method of manufacturing the foam article impregnated with the zinc oxide containing composition is disclosed. In yet another aspect, a method of applying the wound treatment system to a patient's leg is disclosed. In still another aspect, a kit is provided including a foam layer impregnated with a zinc oxide containing composition; optionally, an elastic bandage component (e.g., long or short stretch elastic bandage); and, optionally, an outer stocking or sleeve, wherein the bandage system components are packaged together.
    Type: Application
    Filed: May 28, 2014
    Publication date: September 18, 2014
    Applicant: ANDOVER HEALTHCARE, INC.
    Inventors: Thomas S. Murphy, Khaled El-Tahlawy
  • Publication number: 20140249462
    Abstract: A wound dressing comprising an open-cell foam substrate infused with an ion-containing composition in a water-dispersible carrier is provided. The composition includes citric acid or a salt thereof; salts of potassium, rubidium, and zinc ions; and a carrier comprising two or more polyol components, at least one polyol component being solid at 23 degrees C. A method of treating a wound with said wound dressing is also provided.
    Type: Application
    Filed: July 19, 2012
    Publication date: September 4, 2014
    Applicant: 3M INNOVATATIVE PROPERTIES COMPANY
    Inventors: David R. Holm, Cary A. Kipke
  • Publication number: 20140243725
    Abstract: An antimicrobial medical dressing provides a combination of antimicrobial agents in various concentrations that protect against microorganisms, absorb exudates, and promote healing. The antimicrobial agents may include compositions of ethanol, hydrogen peroxide, and/or ethylenediaminetetraacetic acid.
    Type: Application
    Filed: May 6, 2014
    Publication date: August 28, 2014
    Applicant: Hyprotek, Inc.
    Inventors: Patrick O. Tennican, L. Myles Phipps